Ryan E Terence - Net Worth and Insider Trading

Ryan E Terence Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ryan E Terence owns 1 companies in total, including iBio Inc (IBIO) .

Click here to see the complete history of Ryan E Terence’s form 4 insider trades.

Insider Ownership Summary of Ryan E Terence

Ticker Comapny Transaction Date Type of Owner
IBIO iBio Inc 2012-03-01 Chief Scientific Officer

Ryan E Terence Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ryan E Terence Ownership Network

Ownership Network List of Ryan E Terence

No Data

Ownership Network Relation of Ryan E Terence

Insider Network Chart

Ryan E Terence Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Ryan E Terence is the Chief Scientific Officer of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Ryan E Terence made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 84,655 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,233 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,233 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iBio Inc Insider Transactions

No Available Data

Ryan E Terence Mailing Address

Above is the net worth, insider trading, and ownership report for Ryan E Terence. You might contact Ryan E Terence via mailing address: 9 Innovation Way, Suite 100, Newark De 19711.

Discussions on Ryan E Terence

No discussions yet.